256 related articles for article (PubMed ID: 9007853)
41. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
Miralles A; Ribas C; Olmos G; García-Sevilla JA
J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
[TBL] [Abstract][Full Text] [Related]
42. Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranes.
Le Rouzic M; Angel I; Schoemaker H; Allen J; Arbilla S; Langer SZ
Eur J Pharmacol; 1995 May; 278(3):261-4. PubMed ID: 7589165
[TBL] [Abstract][Full Text] [Related]
43. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
[TBL] [Abstract][Full Text] [Related]
44. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.
De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G
Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210
[TBL] [Abstract][Full Text] [Related]
45. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
46. Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors.
Raasch W; Chun KRJ ; Dendorfer A; Dominiak P
Jpn J Pharmacol; 2000 Sep; 84(1):1-6. PubMed ID: 11043446
[TBL] [Abstract][Full Text] [Related]
47. Imidazoline receptors in vascular smooth muscle and endothelial cells.
Regunathan S; Youngson C; Wang H; Reis DJ
Ann N Y Acad Sci; 1995 Jul; 763():580-90. PubMed ID: 7677378
[TBL] [Abstract][Full Text] [Related]
48. Novel selective compounds for the investigation of imidazoline receptors.
Hudson AL; Gough R; Tyacke R; Lione L; Lalies M; Lewis J; Husbands S; Knight P; Murray F; Hutson P; Nutt DJ
Ann N Y Acad Sci; 1999 Jun; 881():81-91. PubMed ID: 10415900
[TBL] [Abstract][Full Text] [Related]
49. Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes.
Molderings GJ; Moura D; Fink K; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):70-6. PubMed ID: 8377842
[TBL] [Abstract][Full Text] [Related]
50. Binding of [3H]p-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain.
Kamisaki Y; Ishikawa T; Takao Y; Omodani H; Kuno N; Itoh T
Brain Res; 1990 Apr; 514(1):15-21. PubMed ID: 2162708
[TBL] [Abstract][Full Text] [Related]
51. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
52. Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites.
MacInnes N; Handley SL
Neurosci Lett; 2004 Jun; 363(1):11-3. PubMed ID: 15157985
[TBL] [Abstract][Full Text] [Related]
53. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
[TBL] [Abstract][Full Text] [Related]
54. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
Zonnenchein R; Diamant S; Atlas D
Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative.
Greney H; Molines A; Bousquet P; Dontenwill M
Eur J Pharmacol; 1994 Dec; 271(2-3):533-6. PubMed ID: 7705454
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.
Olmos G; Alemany R; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):709-16. PubMed ID: 8971730
[TBL] [Abstract][Full Text] [Related]
57. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.
Vauquelin G; De Backer JP; Ladure P; Flamez A
Ann N Y Acad Sci; 1999 Jun; 881():135-43. PubMed ID: 10415909
[TBL] [Abstract][Full Text] [Related]
58. Interaction of clonidine and rilmenidine with imidazoline-preferring receptors.
Lachaud V; Coupry I; Podevin RA; Dausse JP; Koenig E; Parini A
J Hypertens Suppl; 1988 Dec; 6(4):S511-3. PubMed ID: 3241245
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.
Molderings GJ; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):507-16. PubMed ID: 7643914
[TBL] [Abstract][Full Text] [Related]
60. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
Sastre M; García-Sevilla JA
J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
